Medical Device Contract Research Organization Market Report 2026

The medical device contract research organization market size has grown rapidly in recent years. It will grow from $7.55 billion in 2025 to $8.47 billion in 2026 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to growth in medical device innovation, rising clinical trial complexity, increasing regulatory requirements, early adoption of outsourced research services, expansion of global healthcare infrastructure.

The medical device contract research organization market size is expected to see rapid growth in the next few years. It will grow to $13.28 billion in 2030 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to increase in class iii medical device development, growing demand for faster device approvals, rising investment in medical technology startups, expansion of clinical research in emerging markets, increasing need for post-market surveillance studies. Major trends in the forecast period include increasing outsourcing of medical device clinical trials, rising demand for regulatory and compliance expertise, growth in early-stage preclinical research services, expansion of cro support for high-risk class iii devices, increasing collaboration between device manufacturers and cros.

The rising number of clinical trials is anticipated to drive the expansion of the medical device contract research organization market in the coming years. Clinical trials are research studies conducted on human subjects to evaluate medical treatments, with the objective of determining their safety and efficacy before they are widely adopted in clinical practice. The growth in the number of clinical trials is attributed to advancements in medical technology, the increasing prevalence of chronic diseases, and higher investments in research and development. Medical device contract research organizations support clinical trials by offering specialized expertise, infrastructure, and regulatory guidance to streamline research processes and shorten trial timelines. For example, in December 2024, the Association of the British Pharmaceutical Industry, a UK-based trade association, reported that industry-sponsored clinical trials initiated in the UK rose from 411 in 2022 to 426 in 2023, with Phase III trials increasing by 16.5%, while total participant recruitment across commercial and non-commercial studies jumped from 44,564 in 2022/23 to 150,191 in 2023/24. Consequently, the growing number of clinical trials is propelling the expansion of the medical device contract research organization market.

Major companies operating in the medical device contract research organization market are emphasizing the development of innovative solutions, such as comprehensive contract research organization (CRO) services, to simplify regulatory compliance and improve efficiency in clinical trials. Comprehensive CRO services cover a broad spectrum of support activities, including regulatory compliance and submissions, clinical trial design and management, patient recruitment and retention, data collection and analysis, monitoring and quality assurance, and post-market surveillance. For example, in June 2024, Lindus Health Limited, a UK-based contract research organization, introduced a new comprehensive all-in-one medical device CRO service. This service integrates traditional CRO capabilities with Lindus Health's expertise in medical device clinical trials, encompassing regulatory pathways, participant recruitment, and virtual/hybrid trial solutions. The all-in-one medical device CRO offers medical device companies a wide array of features, including end-to-end CRO and study management, innovative recruitment strategies, study-specific eClinical software, medical device and regulatory expertise, and dedicated site services.

In August 2024, Labquality Corporation, a Finland-based contract research organization (CRO), acquired Scandinavian CRO for an undisclosed amount. Through this acquisition, Labquality enhances its position as a full-service CRO, facilitating further geographical expansion and growth in Scandinavia while strengthening its offerings for the health technology and pharmaceutical sectors. Scandinavian CRO, based in Sweden, provides clinical research services.

Major companies operating in the medical device contract research organization market are Laboratory Corporation of America Holdings, ICON Public Limited Company, Eurofins Scientific Societas Europaea, Pharmaceutical Product Development LLC, WuXi AppTec Co. Ltd., Syneos Health Inc., Charles River Laboratories International Inc., Medpace Holdings Inc., Tigermed Consulting Co. Ltd., Novotech (Australia) Pty Ltd, NAMSA LLC, Promedica International, Excelya, Avania UK Ltd, OSMUNDA MEDICAL DEVICE SERVICE GROUP, CROMSOURCE, Musculoskeletal Clinical Regulatory Advisers LLC, BIO Agile Therapeutics Pvt Ltd, Vial, Qserve Group, CSSi LifeSciences, Medidee Services SA, Eclevar Medtech, Scandinavian CRO, Archer Research, Parexel International Corporation, Clinitude, Geneticist Inc.

North America was the largest region in the medical device contract research organization market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device contract research organization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical device contract research organization market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs affect the medical device contract research organization market by increasing costs associated with imported testing equipment, medical device components, and laboratory supplies. These impacts are more significant in regions with cross-border clinical trial operations, particularly asia-pacific and europe. Higher costs can delay research timelines and increase overall trial expenses. However, tariffs also encourage localization of research activities and strengthen domestic CRO capabilities, supporting regional growth and operational resilience.

The medical device contract research organization market research report is one of a series of new reports that provides medical device contract research organization market statistics, including medical device contract research organization industry global market size, regional shares, competitors with a medical device contract research organization market share, detailed medical device contract research organization market segments, market trends and opportunities, and any further data you may need to thrive in the medical device contract research organization industry. This medical device contract research organization market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A medical device contract research organization is a specialized service provider that performs research and clinical trials on behalf of medical device companies. These organizations focus on carrying out clinical trials and other research activities necessary to develop, test, and validate medical devices.

The primary categories of medical device contract research organizations include finished medical devices, semi-finished medical devices, and medical device raw materials. Finished medical devices are products that have completed the manufacturing process and are ready for use or distribution. These products can be further categorized into Class 1, Class 2, and Class 3, spanning various phases such as preclinical and clinical. They are used across multiple fields, including cardiology, diagnostic imaging, orthopedics, in vitro diagnostics (IVD), ophthalmology, general and plastic surgery, and drug delivery applications.

The medical device contract research organization market includes revenues earned by entities by providing services such as clinical trial management, data collection and database management, preclinical research, medical writing, and project management. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.